Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07390253Active Not Recruiting
Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Neovascular (Wet) Age-Related Macular Degeneration
PrincipalinvestigatorStart date: 2024-09-18
NCT05639049Not ApplicableUnknown
Performance of Two Hydrophobic IOLs
Cataract
PrincipalinvestigatorStart date: 2022-11-01
NCT03152747Completed
Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes
CataractMyopiaPseudophakic Retinal Detachment+1 more
PrincipalinvestigatorStart date: 2017-04-27

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Shenzhi Liang, Doctor

The First Affiliated Hospital of Zhengzhou University

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Emily Y Chew, M.D.

National Eye Institute (NEI)

Related
17 trials

Shared therapeutic areas:

Cataract
Similarity Score6%

Shanjun Cai, Doctor

Zunyi Medical College

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Xiaolin Liang, Doctor

Sun Yat-sen Ophthalmic Center, Sun Yat-sen University

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Lan Li, Master

The First People's Hospital of Kunming

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Hongping Cui, Doctor

Shanghai Oriental Hospital

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Waldemar Carlo, MD

University of Alabama at Birmingham

Related
9 trials

Shared therapeutic areas:

Myopia
Similarity Score6%

Hongmei Zheng, Doctor

People's Hospital of Wuhan University (Hubei Provincial People's Hospital)

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Yaohong Wu, Doctor

Second Hospital of Shanxi Medical University

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Liuhua Tong, Doctor

People's Hospital of Quzhou

Related
1 trials

Shared therapeutic areas:

Neovascular (Wet) Age-Related Macular Degeneration
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07390253PrincipalInvestigator

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Neovascular (Wet) Age-Related Macular Degeneration
Active Not Recruiting
NCT05639049Not ApplicablePrincipalInvestigator

Performance of Two Hydrophobic IOLs

Cataract
Unknown
NCT03152747PrincipalInvestigator

Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes

CataractMyopiaPseudophakic Retinal Detachment+1 more
Completed

All 3 trials loaded